Basal-to-Inflammatory Transition Contributes to Basal Cell Carcinoma Therapy Resistance via Crosstalk with a Pro-Inflammatory Stromal Niche

AFFECTION_STATUS - Case control status of the subject for basal cell carcinoma (BCC); all subjects are BCC patients. (phv00536158.v1.p1)

ANALYTE_TYPE - Analyte Type (phv00536161.v1.p1)
BODY_SITE - Body site where sample was collected (phv00536160.v1.p1)
CONSENT - Consent group as determined by DAC (phv00536153.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00536163.v1.p1)
IS_SPATIAL_TRANSCRIPTOME - SpatialTranscriptomic data (phv00536166.v1.p1)
IS_TUMOR - Tumor status (phv00536162.v1.p1)
PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00536164.v1.p1)
SAMPLE_ID - Sample ID (phv00536159.v1.p1)
SAMPLE_ID - Sample ID (phv00536156.v1.p1)
SUBJECT_ID - Subject ID (phv00536152.v1.p1)
SUBJECT_ID - Subject ID (phv00536155.v1.p1)
SUBJECT_ID - Subject ID (phv00536157.v1.p1)
TUMOR_TREATMENT - Type of tumor treatment for sample (phv00536165.v1.p1)